Draig Therapeutics
Draig
Cardiff, United Kingdom · Founded 2024 · $140.0M raised
- Headquarters
- Cardiff
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- draigtherapeutics.com
- Total Funding
- $140.0M
- Last Round
- $140.0M Series AJun 2025
- Rounds
- 1
About
Draig Therapeutics is a clinical-stage biopharma founded 2024 through partnership between Cardiff University's Medicine Discovery Institute and SV Health Investors. Next-gen neuromodulators for MDD, anxiety, bipolar, PTSD. DT-101 entered Phase 2 in 2025.
Summary
Draig Therapeutics is a Biotech company based in Cardiff, United Kingdom, founded in 2024. It has raised $140.0M in total across 1 round, most recently a $140.0M Series A round in Jun 2025. Investors include Intermediate Capital Group, Schroders and SV Health Investors.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2025
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company